Drugs

Public Comment of Members of the Patient, Consumer, and Public Health Coalition on National Coverage Analysis for Transcatheter Aortic Valve Replacement (TAVR)

Members of the Patient, Consumer, and Public Health Coalition urge CMS to reject a National Coverage...

Patient, Consumer, and Public Health Coalition Comment on Hospital Outpatient Quality Reporting

September 12, 2025: PCPH Coalition comment urges CMS to maintain Outpatient Quality Reporting measures...

Patient, Consumer, and Public Health Coalition Comment on the Reauthorization of MDUFA

September 4, 2025: Our Coalition comment urges that MDUFA VI prioritize patient safety over speed, ensure...

Coalition Written Comment on the Reauthorization of the Prescription Drug User Fee Act 2025

August 14, 2025: The Patient, Consumer, and Public Health Coalition's written comment discusses concerns...

FDA MDUFA Public Meeting Statement of Patient, Consumer, and Public Health Coalition

August 4th, 2025: Tess Robertson-Neel testified on behalf of the Patient, Consumer, and Public Health...

Testimony of Patient, Consumer, and Public Health Coalition at Patient Engagement Device Advisory Committee Meeting

October 30, 2024: Tess Robertson Neel testified at the FDA Patient Engagement Device Advisory Panel on...

Coalition Public Comment to CMS on Transcatheter Tricuspid Valve Replacement Coverage

FDA approval of TTVR was premature and the data are inadequate to support the safety and effectiveness...

Coalition follow-up letter to FDA regarding FDA overruling their own scientists

The Coalition expressed our strong concerns when the Food and Drug Administration (FDA) Center Directors...

Coalition Letter to Senator braun regarding the Promising Pathways Act

The Promising Pathways Act has no safeguards for protecting patients from drugs that have no benefits....

Coalition Comments to FDA on their Guidance for Best Practices for Selecting a Predicate Device to Support a Premarket Notification [510(k)] Submission

In its public comment, members of the Patient, Consumer, Public Health Coalition told FDA that if a predicate...

February 10, 2022

Public Comments to CMS on Aduhelm for the treatment of Alzheimer’s disease

Patient, Consumer, and Public Health Coalition provides public comments on Aduhelm and similar medical products for the treatment of Alzheimer’s disease